Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 06  •  04:00PM ET
199.35
Dollar change
+4.58
Percentage change
2.35
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y17.56% Total Holdings27 Perf Week1.38%
SponsorVan Eck Associates Corporation ETF Type Tagsequity Return% 3Y6.34% AUM395.76M Perf Month-0.13%
Fund Family Bond Type Tagstechnology Return% 5Y1.46% NAV/sh Perf Quarter9.67%
IndexMVIS US Listed Biotech 25 Index Average Maturity Tagsbiotechnology Return% 10Y 52W High202.91 -1.75% Perf Half Y26.58%
Index Weighting Commodity Type Tagsmid-cap Return% SI 52W Low135.34 47.30% Perf YTD5.33%
Active/Passive Quant Type Tags- Flows% 1M0.50% Volatility1.61% 1.31% Perf Year17.56%
Dividend TTM0.96 (0.48%) ESG Type Tags- Flows% 3M0.42% ATR (14)2.95 Perf 3Y18.78%
Dividend Ex-DateDec 22, 2025 Dividend Type Sector/Theme Flows% YTD0.02% RSI (14)57.66 Perf 5Y5.51%
Dividend Gr. 3/5Y8.47% 9.47% Structure Type Region Flows% 1Y Beta0.79 Perf 10Y96.12%
Expense0.35% Growth/Value SMA201.85% Flows% 3Y Rel Volume0.77 Prev Close194.77
Inverse/Leveraged Market Cap SMA502.81% Flows% 5Y Avg Volume8.66K Price199.35
IPODec 21, 2011 Option/ShortYes / Yes SMA20016.61% Trades Volume6,686 Change2.35%
Jan-06-26 06:20AM
Dec-19-25 08:24PM
Nov-04-25 06:20AM
Sep-01-25 06:20AM
Jun-30-25 06:20AM
03:25AM Loading…
May-02-25 03:25AM
Apr-30-25 04:35AM
Apr-29-25 06:20AM
Apr-23-25 05:45AM
Apr-18-25 01:40PM
Apr-04-25 08:30AM
Apr-02-25 07:00AM
Apr-01-25 05:40AM
Mar-29-25 12:50AM
Mar-28-25 06:05AM
04:32PM Loading…
Mar-20-25 04:32PM
Dec-20-24 08:56PM
Dec-15-23 07:57PM
Apr-06-23 08:58AM
Aug-18-22 02:00PM
Jan-31-22 09:38PM
Jan-18-22 01:38PM
Jan-13-22 01:38PM
Jun-30-20 04:26PM
Jun-28-20 04:51PM
Jun-02-20 04:55PM
May-18-20 03:42PM
Feb-27-20 10:43AM
Feb-11-20 05:25PM
Jan-26-20 07:17PM
11:26AM Loading…
Dec-25-19 11:26AM
Dec-10-19 08:33AM
Dec-06-19 01:00PM
Dec-04-19 08:32AM
Dec-02-19 02:40PM
Nov-26-19 07:06PM
Nov-22-19 05:15PM
Nov-21-19 12:56PM
09:40AM
Nov-11-19 02:30PM
Nov-04-19 05:05PM
01:00PM
Sep-03-19 05:46PM
Aug-27-19 10:05AM
Aug-06-19 04:22PM
Jun-26-19 11:00AM
Jun-19-19 11:49AM
May-17-19 07:00AM
May-07-19 04:57PM
Apr-24-19 04:04PM
Apr-05-19 08:00AM
Feb-25-19 10:15AM
Feb-14-19 01:00PM
Jan-24-19 01:00PM
11:34AM
Jan-04-19 10:01AM
Nov-16-18 05:52PM
Oct-17-18 11:48AM
Aug-02-18 12:55PM
Jul-06-18 01:50PM
Jun-27-18 12:15PM
Mar-19-18 04:15PM
Jan-25-18 09:55AM
Jan-10-18 05:40PM
Jan-09-18 11:55AM
Dec-15-17 06:56PM
Nov-22-17 05:30PM
Oct-03-17 06:31AM
Sep-18-17 12:36PM
Sep-11-17 12:05PM
Sep-06-17 09:30AM
Aug-30-17 06:50PM
Aug-24-17 10:36AM
Aug-22-17 02:05PM
Aug-21-17 03:11PM
Aug-03-17 08:24AM
08:15AM
Aug-01-17 10:38AM
12:26AM
Jul-14-17 09:59AM
Jul-13-17 05:33PM
Jul-11-17 07:36AM
Jun-28-17 04:32PM
Jun-23-17 02:43PM
Jun-22-17 11:17AM
Jun-16-17 07:36AM
Jun-13-17 09:06AM
May-31-17 09:54AM
May-15-17 06:00AM
May-13-17 01:14AM
May-11-17 03:52PM
May-10-17 05:08PM
04:24PM
May-03-17 02:58PM
Apr-07-17 11:03AM
Mar-13-17 05:46PM
05:46PM
Mar-08-17 07:07AM
Mar-07-17 09:58AM
Mar-02-17 02:00PM
VanEck Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.